Department of Medical Microbiology and Immunology, CRISS 2.
Center for Antimicrobial Resistance and Epidemiology.
J Infect Dis. 2024 Oct 16;230(4):e777-e788. doi: 10.1093/infdis/jiae204.
Klebsiella pneumoniae is capable of resistance to β-lactam antibiotics through expression of β-lactamases (both chromosomal and plasmid-encoded) and downregulation of outer membrane porins. However, the extent to which these mechanisms interplay in a resistant phenotype is not well understood. The purpose of this study was to determine the extent to which β-lactamases and outer membrane porins affected β-lactam resistance.
Minimum inhibitory concentrations (MICs) to β-lactams and inhibitor combinations were determined by agar dilution or Etest. Outer membrane porin production was evaluated by Western blot of outer membrane fractions. β-lactamase carriage was determined by whole genome sequencing and expression evaluated by real-time reverse-transcription polymerase chain reaction.
Plasmid-encoded β--lactamases were important for cefotaxime and ceftazidime resistance. Elevated expression of chromosomal SHV was important for ceftolozane-tazobactam resistance. Loss of outer membrane porins was predictive of meropenem resistance. Extended-spectrum β-lactamases and plasmid-encoded AmpCs (pAmpCs) in addition to porin loss were sufficient to confer resistance to the third-generation cephalosporins, piperacillin-tazobactam, ceftolozane-tazobactam, and meropenem. pAmpCs (CMY-2 and DHA) alone conferred resistance to piperacillin-tazobactam.
Detection of a resistance gene by whole genome sequencing was not sufficient to predict resistance to all antibiotics tested. Some β-lactam resistance was dependent on the expression of both plasmid-encoded and chromosomal β-lactamases and loss of porins.
肺炎克雷伯菌通过表达β-内酰胺酶(包括染色体和质粒编码的)和下调外膜孔蛋白,能够对β-内酰胺类抗生素产生耐药性。然而,这些机制在耐药表型中相互作用的程度尚不清楚。本研究旨在确定β-内酰胺酶和外膜孔蛋白在多大程度上影响β-内酰胺类抗生素的耐药性。
通过琼脂稀释或 Etest 测定β-内酰胺类抗生素及其抑制剂组合的最小抑菌浓度(MIC)。通过Western blot 检测外膜部分的外膜孔蛋白产生情况。通过全基因组测序确定β-内酰胺酶的携带情况,并通过实时逆转录聚合酶链反应评估表达情况。
质粒编码的β-内酰胺酶对头孢噻肟和头孢他啶的耐药性很重要。染色体 SHV 的高表达对头孢洛扎他巴坦的耐药性很重要。外膜孔蛋白缺失与美罗培南耐药相关。除了外膜孔蛋白缺失外,超广谱β-内酰胺酶和质粒编码的 AmpC(pAmpC)(CMY-2 和 DHA)也足以赋予第三代头孢菌素、哌拉西林他唑巴坦、头孢洛扎他巴坦和美罗培南的耐药性。pAmpC(CMY-2 和 DHA)单独对哌拉西林他唑巴坦耐药。
通过全基因组测序检测到耐药基因并不能充分预测对所有测试抗生素的耐药性。一些β-内酰胺类抗生素耐药性取决于质粒编码和染色体编码的β-内酰胺酶的表达以及外膜孔蛋白的缺失。